ChemSpider 2D Image | Urotensin-II | C64H85N13O18S2

Urotensin-II

  • Molecular FormulaC64H85N13O18S2
  • Average mass1388.566 Da
  • Monoisotopic mass1387.557739 Da
  • ChemSpider ID24646295
  • defined stereocentres - 12 of 12 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

L-α-Asparagine, L-α-glutamyl-L-threonyl-L-prolyl-N-[(4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-4-[[[(1S)-1-carboxy-2-methylpropyl]amino]carbonyl]-7-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylme thyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-19-yl]- [ACD/Index Name]
L-α-Glutamyl-L-threonyl-L-prolyl-N-[(4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-16-benzyl-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-7-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-penta oxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]-L-α-asparagin [German] [ACD/IUPAC Name]
L-α-Glutamyl-L-threonyl-L-prolyl-N-[(4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-16-benzyl-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-7-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-penta oxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]-L-α-asparagine [ACD/IUPAC Name]
L-α-Glutamyl-L-thréonyl-L-prolyl-N-[(4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-16-benzyl-4-{[(1S)-1-carboxy-2-méthylpropyl]carbamoyl}-7-(4-hydroxybenzyl)-13-(1H-indol-3-ylméthyl)-6,9,12,15,18-penta oxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]-L-α-asparagine [French] [ACD/IUPAC Name]
MFCD04115626
Urotensin II human
Urotensin-II [Wiki]
[251293-28-4] [RN]
251293-28-4 [RN]
Urotensin II (114-124), Human
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      7-TM Receptors Tocris Bioscience 1642
      Endogenous vasoactive agonist for the UT receptor Tocris Bioscience 1642
      Peptide Receptors Tocris Bioscience 1642
      Potent endogenous peptide agonist for the urotensin-II receptor (EC50 = 0.1 nM). Displays arterio-selective vasoconstriction and vasodilatation in mammals in vitro and in vivo, effects which vary betw een species. Also has been shown to mediate bronchoconstriction. Tocris Bioscience 1642
      Potent endogenous peptide agonist for the urotensin-II receptor (EC50 = 0.1 nM). Displays arterio-selective vasoconstriction and vasodilatation in mammals in vitro and in vivo, effects which vary between species. Also has been shown to mediate bronchoconstriction. Tocris Bioscience 1642
      Urotensin-II Receptors Tocris Bioscience 1642

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.5±0.1 g/cm3
Boiling Point: 1760.5±65.0 °C at 760 mmHg
Vapour Pressure: 0.0±0.3 mmHg at 25°C
Enthalpy of Vaporization: 295.5±3.0 kJ/mol
Flash Point: 1018.5±34.3 °C
Index of Refraction: 1.677
Molar Refractivity: 356.3±0.4 cm3
#H bond acceptors: 31
#H bond donors: 19
#Freely Rotating Bonds: 27
#Rule of 5 Violations: 3
ACD/LogP: 2.13
ACD/LogD (pH 5.5): -3.80
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 1.00
ACD/LogD (pH 7.4): -4.21
ACD/BCF (pH 7.4): 1.00
ACD/KOC (pH 7.4): 1.00
Polar Surface Area: 553 Å2
Polarizability: 141.2±0.5 10-24cm3
Surface Tension: 87.1±5.0 dyne/cm
Molar Volume: 946.1±5.0 cm3

Click to predict properties on the Chemicalize site






Advertisement